Literature DB >> 14981187

Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.

C Crest1, S Dupont, E Leguern, C Adam, M Baulac.   

Abstract

The authors conducted an open study of levetiracetam as add-on therapy in nine patients with well-defined progressive myoclonic epilepsies and refractory myoclonus. Myoclonus was evaluated semiquantitatively (territory, intensity, daily living activities). Five patients had improvement of their myoclonus score. Levetiracetam may benefit myoclonus in progressive myoclonic epilepsy.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14981187     DOI： 10.1212/01.wnl.0000110193.78872.dd

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  9 in total

1.  Angelman syndrome: need for further illumination in the theater of the happy puppet.

Authors:  Raman Sankar
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

Review 2.  Medical management of Lennox-Gastaut syndrome.

Authors:  Aspasia Michoulas; Kevin Farrell
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 3.  Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies.

Authors:  Edoardo Ferlazzo; Dorothee Kasteleijn-Nolst Trenite; Gerrit-Jan de Haan; Felix Felix Nitschke; Saija Ahonen; Sara Gasparini; Berge A Minassian
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

4.  Efficacy and safety of levetiracetam in pediatric epilepsy.

Authors:  Ahmed A Elberry; Rawabi K Felemban; Rawan H Hareeri; Sawsan M Kurdi
Journal:  Saudi Pharm J       Date:  2011-06-15       Impact factor: 4.330

5.  Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.

Authors:  Tibor Kovács; Marianna Farsang; Edina Vitaszil; Péter Barsi; Tamás Györke; Imre Szirmai; Anita Kamondi
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

6.  Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.

Authors:  Mubashira Hashmi; Feroza Saleem; Muhammad Shahid Mustafa; Mughis Sheerani; Zeeshan Ehtesham; Khurram Siddiqui
Journal:  BMJ Case Rep       Date:  2010-11-05

7.  Levetiracetam in three cases of progressive myoclonus epilepsy.

Authors:  Savvas Papacostas; Elena Kkolou; Eleftherios Papathanasiou
Journal:  Pharm World Sci       Date:  2007-01-23

8.  Progressive myoclonic epilepsy type 1: Report of an Emirati family and literature review.

Authors:  Mohammed Saadah; Mahfoud El Beshari; Loai Saadah; Hisham Hamdallah; Zeinab Alloub; Amani Ali Al Zaabi; Abdelmatlob Ben-Mussa; Anwaar Ben-Nour
Journal:  Epilepsy Behav Case Rep       Date:  2014-05-04

9.  Levetiracetam in the treatment of epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.